A phase II study of gemcitabine and oxaliplatin (Oxigem) in unresectable gall bladder cancer

Cancer Chemotherapy and Pharmacology

Volumn 65, Issue 3, 2010, Pages 497-502

  Sharma, Atul ^a   Mohanti, Bidhu ^a   Raina, Vinod ^a   Shukla, Nootan ^a   Pal, Sujoy ^b   Dwary, Amit ^a   Deo, Surya ^a   Sahni, Peush ^b   Garg, Pramod ^b   Thulkar, Sanjay ^a   Dattagupta, Siddhartha ^b   Rath, Goura ^a  

^a INSTITUTE ROTARY CANCER HOSPITAL   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Gall bladder cancer; Gemcitabine; Oxaliplatin

Indexed keywords

GEMCITABINE; OXALIPLATIN; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; PLATINUM COMPLEX;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GALLBLADDER CANCER; HUMAN; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NEUROPATHY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT RESPONSE; CHEMICALLY INDUCED DISORDER; FOLLOW UP; GALLBLADDER TUMOR; MIDDLE AGED; PATHOLOGY; SURVIVAL; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DEOXYCYTIDINE; DIARRHEA; FEMALE; FOLLOW-UP STUDIES; GALLBLADDER NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MUCOSITIS; ORGANOPLATINUM COMPOUNDS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VOMITING;

EID: 75549085979     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-009-1055-0     Document Type: Article

References (22)

1. National Cancer Registry Program. Consolidated Report of Population Based Cancer Registries 2001-2004. Indian Council of Medical Research Publication. http://www.icmr.nic.in/ncrp/report-pop-2001-2004, p 21
2. EC Lazcano-Ponce JF Miquel N Muñoz, et al. 2001 Epidemiology and molecular pathology of gall bladder cancer CA Cancer J Clin 51 349 10.3322/canjclin.51.6.349 1:STN:280:DC%2BD38%2FjsVOjtw%3D%3D 11760569
3. T Takada H Kato T Matsushiro Y Nimura T Nagakawa T Nakayama 1994 Comparison of 5-fluorouracil, doxorubicin, and mitomycin with 5-fluorouracil alone in the treatment of pancreatic-biliary carcinomas Oncology 51 396 400 10.1159/000227373 1:STN:280:DyaK2czivFektg%3D%3D 8052479
4. T Okusaka H Ishii A Funakoshi, et al. 2006 Phase II study of single agent gemcitabine in patients with advanced biliary tract cancer Cancer Chemother Pharmacol 57 647 653 10.1007/s00280-005-0095-3 1:CAS:528:DC%2BD28XhsVartLY%3D 16142487 (Pubitemid 43237850)
5. Sharma Atul Bedi Rajeev K Shukla Nootan, et al. 2004 Does chemotherapy improves survival in gall bladder cancer? Proc Am Soc Clin Oncol 362 4202
6. A Sharma V Raina NK Shukla, et al. 2002 Folonic acid, and 5 fluorouracil in advanced/unresectable adenocarcinoma of gall bladder: a pilot study Proc Am Soc Clin Oncol 21 142b
7. C Hsu Y-C Shen C-H Yang, et al. 2004 Weekly gemcitabine plus 24 hour infusion of 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of biliary tract Br J Cancer 90 1715 1719 1:CAS:528: DC%2BD2cXkvFWlur4%3D 15150619
8. DC Doval JS Shekhon SK Gupta, et al. 2004 A phase II study of gemcitabine and cisplatin in chemotherapy naïve, unresectable gall bladder cancer Br J Cancer 90 1516 1520 10.1038/sj.bjc.6601736 1:CAS:528:DC%2BD2cXjtVWktL4%3D 15083178 (Pubitemid 38648231)
9. T André C Tournigand O Rosmorduc, et al. 2004 GERCOR Group. Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study Ann Oncol 15 1339 1343 10.1093/annonc/mdh351 15319238 (Pubitemid 39295020)
10. B Glimelius K Hoffman PO Sjödén G Jacobsson, et al. 1996 Chemotherapy improves survival and quality of life in pancreatic and biliary tract cancer Ann Oncol 7 593 600 1:STN:280:DyaK2s%2FjtlOitw%3D%3D 8879373
11. T Takada Y Nimura H Katoh, et al. 1998 Prospective randomized trial of 5 fluorouracil, doxorubicin, and mitomycin C for non respectable pancreatic and biliary carcinoma: multicenter randomized trial Hepatogastroenterology 45 2020 2026 1:CAS:528:DyaK1MXhtFKjsbc%3D 9951857
12. MO Perpetuo M Valdivieso LK Heilbrun, et al. 1978 Natural history study of gallbladder cancer: a review of 36 years experience at M.D. Anderson Cancer Center Cancer 42 330 10.1002/1097-0142(197807)42:1<330::AID- CNCR2820420150>3.0.CO;2-F 1:STN:280:DyaE1c3ht1Kksw%3D%3D 667804
13. J Gallardo M Fodor C Gamargo L Orlandi 1998 Efficacy of gemcitabine in the treatment of patients with gallbladder: a case report Cancer 83 2419 2421 10.1002/(SICI)1097-0142(19981201)83:11<2419::AID-CNCR23>3.0.CO;2-9 1:STN:280:DyaK1M%2FlsVakug%3D%3D 9840543 (Pubitemid 28533513)
14. MP Castro 1998 Efficacy of gemcitabine in the treatment of patients with gallbladder: a case report Cancer 82 639 641 10.1002/(SICI)1097-0142(19980215) 82:4<639::AID-CNCR4>3.0.CO;2-G 1:STN:280:DyaK1c7jsF2lsw%3D%3D 9477094 (Pubitemid 28090273)
15. JO Gallardo B Rubio M Fodor, et al. 2001 A phase II study of gemcitabine in gall bladder carcinoma Ann Oncol 12 1403 1406 10.1023/A:1012543223020 1:STN:280:DC%2BD38%2FjsFaksA%3D%3D 11762811 (Pubitemid 33100245)
16. M Raderer MH Hejna JB Valencak, et al. 1999 Two consecutive phase II studies of 5-fluorouracil/leucovorin/mitomycin C and of gemcitabine in patients with advanced biliary cancer Oncology 56 177 180 10.1159/000011961 1:CAS:528:DyaK1MXisFGhsbg%3D 10202270
17. S Thongprasert S Napapan C Charoentum S Moonprakan 2005 Phase II study of gemcitabine and cisplatin as first line chemotherapy in inoperable biliary tract carcinoma Ann Oncol 16 279 281 10.1093/annonc/mdi046 1:STN:280: DC%2BD2M%2FjvFyhsw%3D%3D 15668284 (Pubitemid 40309310)
18. J Harder B Riecken O Kummer, et al. 2006 Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer Br J Cancer 95 848 852 10.1038/sj.bjc.6603334 1:CAS:528:DC%2BD28XhtVans7jK 16969352 (Pubitemid 44498100)
19. C Louvet T André G Lledo, et al. 2002 Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study J Clin Oncol 20 1512 1518 10.1200/JCO.20.6.1512 1:CAS:528:DC%2BD38XivFeitr4%3D 11896099 (Pubitemid 34260530)
20. JJ Knox D Hedley A Oza, et al. 2005 Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial J Clin Oncol 23 2332 2338 10.1200/JCO.2005.51.008 1:CAS:528:DC%2BD2MXjsVyhsr0%3D 15800324 (Pubitemid 46218726)
21. RP Riechelmnn CA Townsley SN Chin GR Pond JJ Knox 2007 Expanded phase II trial of gemcitabine and capecitabine for advanced biliary tract cancer Cancer 110 1307 1312 10.1002/cncr.22902 (Pubitemid 47435603)
22. T André JM Reyes-Vidal L Fartoux, et al. 2008 Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study Br J Cancer 99 6 862 867 10.1038/sj.bjc.6604628 19238628